Left ventricular hypertrophy and hypertension

Area of Science:

• Cardiology
• Hypertension Research
• Cardiovascular Imaging

Background:

• Hypertension (HTN) is a primary modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality.
• The left ventricle (LV) is a key organ affected by HTN, leading to geometrical changes.
• These LV abnormalities, including concentric remodeling and LV hypertrophy (LVH), are independent risk factors for adverse outcomes.

Purpose of the Study:

• To provide a comprehensive review of the literature on the relationship between HTN and LV geometry abnormalities.
• To focus on the diagnostic, prognostic, pathophysiological, and therapeutic aspects of HTN-induced LV changes.

Main Methods:

• Systematic literature review.
• Analysis of diagnostic imaging techniques for LV geometry.
• Review of pathophysiological mechanisms linking HTN and LV remodeling.
• Evaluation of treatment strategies for LVH in hypertensive patients.

Main Results:

• HTN significantly impacts LV geometry, leading to remodeling and hypertrophy.
• LV geometrical changes are strong predictors of CVD, all-cause mortality, and neurological events.
• Blood pressure control through lifestyle modifications and antihypertensive medications can prevent and reverse LVH.

Conclusions:

• HTN-induced LV geometrical abnormalities represent a critical aspect of HTN management.
• Early diagnosis and effective blood pressure control are essential to mitigate the risks associated with LVH.
• Further research into pathophysiological mechanisms and targeted therapies can improve outcomes for hypertensive patients with LV abnormalities.